T&R Biofab Co., Ltd. (KOSDAQ:246710)
South Korea · Delayed Price · Currency is KRW 2,275.00
+10.00 (0.44%)
Sep 1, 2026, 3:30 PM KST
T&R Biofab Market Cap
T&R Biofab has a market cap or net worth of 107.96 billion as of August 31, 2026. Its market cap has increased by 84.89% in one year.
Market Cap
107.96B
Enterprise Value
130.69B
Revenue
29.73B
Ranking
n/a
PE Ratio
n/a
Stock Price
2,275.00
ChartMarket Cap Chart
Since November 28, 2018, T&R Biofab's market cap has increased from 101.48B to 107.96B, an increase of 6.39%. That is a compound annual growth rate of 0.80%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 1, 2026 | 107.96B | -39.78% |
| Dec 30, 2025 | 179.28B | 91.93% |
| Dec 30, 2024 | 93.41B | -51.40% |
| Dec 28, 2023 | 192.21B | -20.80% |
| Dec 29, 2022 | 242.68B | -53.25% |
| Dec 30, 2021 | 519.07B | 265.38% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Nov 28, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 70.19T |
| Celltrion | 45.34T |
| ALTEOGEN | 21.41T |
| Samsung Epis Holdings | 9.61T |
| HANDOK | 123.54B |
| Genexine | 120.29B |
| Jeil Pharma Holdings | 114.37B |
| HLB Pharmaceutical | 99.84B |